Check out your Company Bowl for anonymous work chats.
Join us in celebrating German Diversity Day and echoing the “Voice for Diversity” – this year’s motto. Together with the Charta der Vielfalt e.V. and their members and signatories, we're committed to fostering diversity in the workplace and elevating the conversation about its value. Each of the 14,600 voices at Sartorius brings in a unique tone and we believe that the mix of cultures, genders, identities, ages, educational backgrounds, and more leads to better solutions for our life science and biopharma customers. Learn more about diversity at our company: https://sar.to/0817n
On the path to gender parity, our sites in France are well on track with a proportion of 49% women and 51% men. And in China, with 47% the percentage is also quite high. Across the entire company, 5,994 women at Sartorius are united by the ambition to help translate scientific discoveries into real-world medicine faster: from engineers, to scientists, to IT professionals. Let’s take a look at our management levels: In 2023, Alexandra Gatzemeyer was the first woman to join the four-member Executive Board at Sartorius. All in all, 31% of people in leadership positions both directly below the Board level and on the second management level at Sartorius are female. With these numbers, the company is well on its way to meeting its target of having one-third women at the two management levels below the Executive Board by the end of 2025. And did you know that our employee resource groups, such as the Sartorius Business Women's Association or the LGBT+ Friends Alliance, foster gender parity and increase visibility and acceptance of employees regardless of gender, expression or identity? Learn more about diversity at Sartorius: www.sartorius.com/diversity
Sartorius is expanding its multidisciplinary collaboration with NVIDIA to help enable the development of new and better therapies, combining Sartorius’ in-depth knowledge of life sciences and bioprocessing with NVIDIA’s AI-powered computing platforms and software. "Biological interactions are exceptionally complex. Making better use of data by integrating life science expertise with AI solutions is a promising approach to simplify and accelerate biopharma drug discovery and manufacturing progress. This expanded collaboration with NVIDIA will help result in relevant technological innovations for our customers and ultimately for patients," said Prof. Dr. Oscar-Werner Reif, Chief Technology Officer of Sartorius. Read media release: https://ow.ly/i4Lo50RHVtM
From local roots to global reach: With our origins in the heart of Europe and the largest growth markets abroad, Sartorius is a true global player – and our staff has become increasingly international in recent years. Today, Sartorius unites people from 113 nations – this means that more than half of all countries worldwide are represented in the company. Today, some 14,600 people across the globe, team up to find creative ways that make our customers’ lives easier and our vision of “better health for more people” a reality. Nearly one-third come from the company’s home country Germany, followed by the United States, one of the industry’s biggest growth markets, and France, where Sartorius Stedim Biotech is at home. And did you know that we have three nationalities on the four-person Executive Board of Sartorius AG? Learn more about diversity at Sartorius: www.sartorius.com/diversity
Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to commercialize ICB platforms based on prototypes developed by Sanofi. In return, Sanofi will grant Sartorius exclusive access to its know-how and patents related to the ICB platform. “Technological innovation is crucial for biopharmaceutical companies to significantly reduce the cost of drug manufacturing - while improving the environmental footprint of their operations – and ultimately getting life-saving drugs to patients faster,” said Jan Schäfer, Head of Separation Systems at Sartorius. “This collaboration will help Sartorius to further expand its position as a leading company in the field of integrated and continuous bioprocessing.” Read media release: https://ow.ly/gReA50REhBO
May is European Diversity Month. We are taking this as an opportunity to share facts on various dimensions of diversity at Sartorius over the next four weeks. How many nationalities work in the company, how old are our people, and where does Sartorius stand in terms of gender distribution? We are going to address all of this. You don’t talk about age? We do, because at Sartorius, the mix of young talents and experienced professionals is crucial for the company’s success. With around 38% the majority of employees are between 30-39 years old. Nearly 24% are 40-49 years, around 22% are 50 years or older and a bit more than 16% are 29 years or younger. This means, at Sartorius, "baby boomers", Gen X, Y and Z work side by side to create innovative solutions for our customers. While our young colleagues value the experience and knowledge of our more seasoned employees, our experienced professionals welcome the fresh perspectives and insights of our juniors. This collaborative environment fosters continuous learning and growth for the benefit of our teams and customers alike. Learn more about diversity at Sartorius: www.sartorius.com/diversity
📸 Get some impressions of Sartorius’ contribution to the ADAN Career Day, Europe’s biggest career fair for black and people of color, in Frankfurt am Main, Germany. Throughout the event, our recruiting team engaged with candidates, from fresh graduates to seasoned managers, answering numerous questions, addressing queries and fostering connections. Highlights included a company presentation showcasing our commitment to diversity, speed dating interviews, and a panel talk discussion which offered the chance to exchange insights and experiences on how to navigate diversity, equity and inclusion in Corporate Germany. “The need for diversity is evident in our everyday corporate life: The combination of diverse perspectives leads to a better understanding of our customers and to more innovative solutions. That’s why we are dedicated to attracting talents with diverse backgrounds and abilities. We met many such talents at ADAN Career Day and have already scheduled further dialogue with twenty individuals,” said Otto Vazquez Dominguez, Head of Talent Acquisition at Sartorius. Learn more about careers and diversity at Sartorius: www.sartorius.com/careers Photo credit: ADAN.careers
First quarter results in line with expectations "In the first quarter we largely saw the projected muted start to the fiscal year and a mixed picture overall: Orders in our core business with consumables are picking up noticeably, signaling an advanced stage of inventory reduction on the customer side. Business with customers working on cell and gene therapies, which is a major strategic focus for us, is also developing well, although this still very young field generally sees somewhat higher volatility. In contrast, customers, particularly in China and to some extent also in Europe, showed a pronounced reluctance to invest, which had a significant dampening effect on our equipment business," said CEO Joachim Kreuzburg. ➡ Q1 results in line with expectations ➡ Recurring business with significant order growth ➡ Inventory reductions at customers further advanced ➡ Demand from China remains weak ➡ Outlook for full year confirmed Read media release: https://lnkd.in/eut26Pcm
Sartorius and U.S.-based startup TheWell Bioscience have agreed to partner on the further development of hydrogels and bioinks tailored to produce 3D advanced cell models for drug discovery workflows. TheWell’s solutions address the shift from animal-based to more human-relevant organoid models, resulting in more accurate predictions in drug discovery. „The offering seamlessly complements our bioanalytic instruments, cytokines and media products used to grow and analyze a range of 3D spheroid and organoid models. Their hydrogel solutions are highly compatible with our live-cell imaging system for monitoring and analyzing cell health and behavior in real time. By collaborating, we will enable customers to get more relevant insights in less time, accelerating time to market," said Fiona Coats, Head of Marketing at Sartorius’ Lab Products & Services division. Media release: https://ow.ly/ozOz50Rbo46
On today’s Global Recycling Day, Sartorius stands by its commitment to the concept of a circular economy – striving to minimize waste and maximize the use of resources. Did you know that we recently set a goal to achieve zero waste to landfill until 2030? In the ambition to increase the recycling rates in our own production, teams at the production sites in Göttingen, Germany, and Aubagne, France, have run recycling initiatives – with measurable results. Learn more on the Sartorius Blog: https://srtrs.info/bmbyd
